Quanterix Corporation (QTRX)
NASDAQ: QTRX · Real-Time Price · USD
9.61
+0.07 (0.73%)
Jan 29, 2025, 4:00 PM EST - Market closed
Quanterix Revenue
Quanterix had revenue of $35.81M in the quarter ending September 30, 2024, with 13.48% growth. This brings the company's revenue in the last twelve months to $133.81M, up 14.72% year-over-year. In the year 2023, Quanterix had annual revenue of $122.37M with 15.96% growth.
Revenue (ttm)
$133.81M
Revenue Growth
+14.72%
P/S Ratio
2.74
Revenue / Employee
$303,422
Employees
441
Market Cap
476.39M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 63.17B |
AbbVie | 55.53B |
AstraZeneca | 51.21B |
Novartis AG | 49.94B |
Thermo Fisher Scientific | 42.37B |
Abbott Laboratories | 41.95B |
QTRX News
- 10 hours ago - Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewsWire
- 14 hours ago - Quanterix Corporation Is Being Investigated For Securities Law Violations And Affected Investors Are Urged To Contact The Schall Law Firm - Accesswire
- 1 day ago - Bragar Eagel & Squire, P.C. Is Investigating Quanterix and TransMedics and Encourages Investors to Contact the Firm - GlobeNewsWire
- 1 day ago - The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Quanterix Corporation For Securities Fraud - Accesswire
- 2 days ago - Quanterix Corporation Is Being Investigated For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm - Accesswire
- 15 days ago - Quanterix Provides Update on Financial Performance - Business Wire
- 19 days ago - AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA - Business Wire
- 19 days ago - Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers - Business Wire